Corteva (NYSE:CTVA) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

Corteva (NYSE:CTVA) had its price objective raised by analysts at Deutsche Bank Aktiengesellschaft from $90.00 to $100.00 in a research note issued to investors on Monday,MarketScreener reports. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 22.17% from the stock’s previous close.

Several other research analysts also recently weighed in on CTVA. Wolfe Research upped their price target on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. BNP Paribas Exane lifted their price target on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Mizuho boosted their price target on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Royal Bank Of Canada increased their price objective on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, CICC Research raised their price objective on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $87.52.

Corteva Stock Performance

Shares of Corteva stock traded down $0.98 on Monday, hitting $81.85. 285,350 shares of the company’s stock were exchanged, compared to its average volume of 3,995,957. Corteva has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a 50-day simple moving average of $80.83 and a 200-day simple moving average of $72.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a market capitalization of $54.75 billion, a PE ratio of 48.05, a PEG ratio of 2.64 and a beta of 0.59.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts anticipate that Corteva will post 3.67 EPS for the current year.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.15% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Corteva

Several hedge funds have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. grew its stake in shares of Corteva by 0.7% during the first quarter. PNC Financial Services Group Inc. now owns 678,065 shares of the company’s stock valued at $56,761,000 after buying an additional 4,930 shares during the last quarter. Oslo Pensjonsforsikring AS bought a new stake in shares of Corteva during the 1st quarter worth approximately $281,000. Baader Bank Aktiengesellschaft purchased a new position in Corteva during the 1st quarter valued at $277,000. Wilkerson Advisory Group LLC boosted its holdings in Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after acquiring an additional 133 shares during the period. Finally, Cassaday & Co Wealth Management LLC bought a new position in Corteva in the 1st quarter valued at $80,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.